Buprenorphine/granisetron controlled release - Camurus/BraeburnAlternative Names: BB0417; CAM 2058
Latest Information Update: 28 Nov 2016
At a glance
- Originator Camurus
- Class Analgesics; Antiemetics; Azabicyclo compounds; Cyclopropanes; Indazoles; Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Nociceptin receptor agonists; Opioid delta receptor antagonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists; Serotonin 3 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Postoperative nausea and vomiting; Postoperative pain